Improving treatment decisions in inflammatory bowel disease with validated and standardised microbiome analysis

• Unité de recherche: INNOSUISSE
• Numéro de projet: 119.930 IP-LS
• Titre du projet anglais: Improving treatment decisions in inflammatory bowel disease with validated and standardised microbiome analysis

Mots-clé (Anglais)

Life sciences, Human medicine

Résumé des résultats (Abstract) (Anglais)

We will set a new gold standard in microbiome analysis by extending the current 16S approach and CALEX® device-based automation. Advancing to better species resolution and activity assessment through metabolomics, new combined databases will lead to more profound therapeutic decisions e.g. in IBD.